Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome

Human Reproduction

Volumn 19, Issue 11, 2004, Pages 2474-2483

  Kashyap, Sonya ^a,b,c   Wells, George A ^a   Rosenwaks, Zev ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Clomiphene citrate; Insulin sensitizers; Meta analysis; Metmorfin; Polycystic ovarian syndrome

Indexed keywords

CLOMIFENE CITRATE; INSULIN SENSITIZING AGENT; METFORMIN; PLACEBO;

AUTOMATION; BIBLIOGRAPHIC DATABASE; CLINICAL OBSERVATION; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; HUMAN; MEDICAL LITERATURE; MENSTRUAL CYCLE; META ANALYSIS; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY; QUALITATIVE RESEARCH; RANDOMIZATION; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

ALCES ALCES;

EID: 8344289055     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh440     Document Type: Review

References (44)

1. Adams J, Polson JW, Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293,355-359.
2. Berlin JA (1997) Does blinding of readers affect the results of meta-analysis? Lancet 350,185-186.
3. Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D and Laupacis A (1999) Assessing the reliability of randomized trials: reliability of the Jadad scale. Controlled Clin Trials 20,448-452.
4. Dale P, Tanbor T and Vaaler S (1992) Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 58,487-491.
5. Eijkemans MJC, Imani B, Molders AGMGJ, Habbema JDF and Fauser BCJM (2003) High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 18,2357-2362.
6. El-Biely MM and Habba M (2001) The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndome. Mid East Fertil Soc J 6,43-49.
7. Elkind-Hirsch K, Valdes C and McConnel T (1991) Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women. Fertil Steril 55,486.
8. ESHRE and ASRM (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome*1. Fertil Steril 81,19-25.
9. Farquhar, C., Vandekerckhove, P., Lilford, R (2001) Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome [update of Cochrane Database Syst Rev. 2000;(2): CD001122; PMID: 10796746]. Cochrane Database of Systematic Reviews CD001122.
10. Fleming R, Hopkinson ZE, Wallace M, Greer IA and Sattar N (2002) Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 87,569-574.
11. Flight, N.R (2002) Insulin-sensitizing drugs for polycystic ovary syndrome (protocol). The Cochrane Library.
12. Glueck C, Wang P, Fontaine R, Tracy T and Sieve-Smith L (1999) Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovarian syndrome. Metab Clin Exp 48,511-519.
13. Glueck CJ, Wang P, Kobayashi S, Phillips H and Sieve-Smith L (2002) Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 77,520-525.
14. Gorlitsky G, Kase N and Speroff L (1978) Ovulation and pregnancy rates with clomiphene citrate. Obstet Gynecol 51,265-269.
15. Imani B, Eijkemans MJC, te Velde ER, Habbema JDF and Fauser BCJM (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83,2361-2365.
16. Imani B, Eijkemans MJC, te Velde ER, Habbema JDF and Fauser BCJM (1999) Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84,1617-1622.
17. Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds JM, Gavaghan D and McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 17,1-12.
18. Jadad AR, Moher D and Klassen TP (1998) Guides for reading and interpreting systematic reviews: II. How did the authors find the studies and assess their quality? Arch Pediatr Adolesc Med 152,812-817.
19. Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R and Nestler JE (2001) Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 86,1126-1133.
20. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA and Nestler JE (2002) Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 87,524-529.
21. Juni P, Holenstein F, Sterne J, Bartlett C and Egger M (2002) Direction and impact of language bias in meta-analyses of controlled trials: empirical study [comment]. Int J Epidemiol 31,115-123.
22. Kocak M, Caliskan E, Simsir C and Haberal A (2002) Metformin improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 77, 101-106.
23. Kousta E, White DM and Franks S (1997) Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 3,359.
24. Lord JM, Flight IHK and Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J 327,951-950.
25. Loverro G, Lorusso F, De PagolaNicolardi G, Mei L and Selvaggi L (2002) Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovarian syndrome. Gynecol Endocrinol 16,217-224.
26. Lunenfeld B, Pariente C, Dor J, Menashe Y, Seppala M, Mortman H and Insler V (1991) Modern aspects of ovulation induction. Ann NY Acad Sci 626,207-216.
27. Malkawi HY and Qulban HS (2002) The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Saudi Med J 23,663-666.
28. McAuley L, Pham B, Tugwell P and Moher D (2000) Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet 356,1228-1231.
29. Messinis IE and Milingos SD (1997) Current and future status of ovulation induction in polycystic ovary syndrome. Hum Reprod Update 3,235-253.
30. Mitkov M, Simenov S and Pehlivanov B (2002) Effect of metformin treatment of polycystic ovary syndrome. Endocrinologia 7,25-29.
31. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E and Muggeo M (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85,139-145.
32. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K and Penna A (1996) Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. [comment]. Lancet 347,363-366.
33. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D and Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses [comment]. Lancet 354,1896-1900.
34. Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR and Liberati A (2000) What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 53,964-972.
35. Nagamani M, Dinh T and Kelver M (1986) Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol 154,384.
36. Nestler JE and Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17{alpha} activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335, 617-623.
37. Nestler JE, Jakubowicz DJ, Evans WS and Pasquali R (1998) Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med 338,1876-1880.
38. Ng EHY, Wat NMS and Ho PC (2001) Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries:a randomized, double-blind placebo-controlled trial. Hum Reprod 16,1625-1631.
39. Singh I, Bedaiwy MA, Hatwal A, Kumar A and Agarwal A (2001) Increased pregnancy rates with metformin and clomiphene citrate in non-obese patients with polycystic ovary syndrome: prospective randomized study. Fertil Steril 76,S94.
40. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. J Am Med Assoc 283,2008-2012.
41. Sturrock NDC, Lannon B and Fay TN (2001) Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br J Pharmacol 53,469-473.
42. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kumma SW and Nestler JE (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75,310-315.
43. Velazquez E, Mendoza S, Hamer T, Sosa F and Glueck C (1994) Metformin therapy in polycystic ovarian syndrome reduces hyperinsulinema, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metab Clin Exp 43,647-654.
44. Yarali H, Yildiz BO, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O and Koray Z (2002) Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod 17,289-294.